NCT00194922View on ClinicalTrials.gov

Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Irritable Bowel Syndrome (IBS)

Interventions

DIETARY_SUPPLEMENT

E. Coli Strain M17 Probiotic

30 ml PO BID for 12 weeks

Trial Locations (1)

10021

Cornell Weill Medical College, New York

Sponsors

Collaborators (1)

BioBalance Corporation

All Listed Sponsors

collaborator

BioBalance Corporation

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT00194922 - Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) | Biotech Hunter | Biotech Hunter